Date: Tuesday, 10 November, 2015
Starting at: 16:00 GMT
New rules on the margining of non-cleared OTC derivatives contracts are coming into force soon. If you are a fund manager, these rules will profoundly affect your:
portfolio management costs
outsourcing arrangements; and
operational costs and procedures.
To help you manage these impacts, COO Connect is hosting a webinar on how to cope with the new rules on Tuesday 10 November at 4:00 pm (GMT), 5:00 pm (CET), 9:00 am (EST). Complete our short poll to register now.
The topics to be discussed include:
Coping with different rules in different jurisdictions
State of readiness of the fund management industry for the new rules
Coping with increases in margin call volume
Obtaining cash to meet margin calls
Difficulty of cross-currency collateralisation
Coping with standardised or risk-based initial margin models
Difficulty of coping with concentration limits
Managing re-documentation of client CSAs
Managing legacy OTC derivative positions
Segregation of collateral
Rehypothecation of collateral
This webinar is sponsored by Omgeo, the post-trade processing arm of the DTCC.
The webinar will be moderated by COOConnect founding partner Dominic Hobson, and will include the following panellists:
Opening and closing remarks by Dominic Hobson, Founder of COOConnect.
Paul Quarto, Director of Product Management and Professional Services in the Collateral Management group of Omgeo, LLC – a division of the DTCC. Paul Joined DTCC/Omgeo in 2005. In his current role, Paul is focused on Collateral Management products and services. His global responsibilities include oversight for pre-sales, product management, and client implementation activities.
Will Winterton, Senior Associate at Clifford Chance in London. Will is a Senior Associate in the derivatives and structured products group, having spent several years with the group in Tokyo and Hong Kong. He specialises in derivatives, counterparty risk management, collateral and clearing issues, for both sell- and buy-side clients. Recently, Will has been focussing on exchange traded derivative and OTC derivative documentation developments in both cleared and uncleared worlds and he has been involved in a number of industry initiatives in connection with this.